Insmed Operating Margin vs. Net Income
| INSM Stock | USD 158.62 0.41 0.26% |
Insmed Operating Profit Margin |
|
For Insmed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Insmed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Insmed Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Insmed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Insmed Inc over time as well as its relative position and ranking within its peers.
Check out Risk vs Return Analysis. Will Biotechnology sector continue expanding? Could Insmed diversify its offerings? Factors like these will boost the valuation of Insmed. Market participants price Insmed higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.17) | Revenue Per Share | Quarterly Revenue Growth 1.526 | Return On Assets | Return On Equity |
Investors evaluate Insmed Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Insmed's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Insmed's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Insmed's market price signifies the transaction level at which participants voluntarily complete trades.
Insmed Inc Net Income vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. Insmed Inc is rated below average in operating margin category among its peers. It also is rated below average in net income category among its peers . At this time, Insmed's Operating Profit Margin is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Insmed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Insmed Net Income vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Insmed |
| = | (0.95) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Insmed |
| = | (1.28 B) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Insmed Net Income Comparison
Insmed is currently under evaluation in net income category among its peers.
Insmed Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Insmed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Insmed will eventually generate negative long term returns. The profitability progress is the general direction of Insmed's change in net profit over the period of time. It can combine multiple indicators of Insmed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.5 M | 1.5 M | |
| Operating Income | -1.2 B | -1.1 B | |
| Total Other Income Expense Net | -95 M | -90.3 M | |
| Net Loss | -1.3 B | -1.2 B | |
| Income Tax Expense | 5 M | 5.3 M | |
| Income Before Tax | -1.3 B | -1.2 B | |
| Net Loss | -433.4 M | -411.7 M | |
| Net Loss | -822.4 M | -781.3 M | |
| Non Operating Income Net Other | 3.3 M | 3.4 M | |
| Interest Income | 2.6 M | 2.4 M | |
| Net Interest Income | -76.4 M | -72.6 M | |
| Change To Netincome | 53.2 M | 28.4 M | |
| Net Loss | (5.98) | (6.28) | |
| Income Quality | 0.73 | 0.62 | |
| Net Income Per E B T | 1.00 | 0.79 |
Insmed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Insmed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Insmed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Insmed's important profitability drivers and their relationship over time.
Insmed Earnings Estimation Breakdown
The calculation of Insmed's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Insmed is estimated to be -0.8346 with the future projection ranging from a low of -1.35 to a high of -0.45. Please be aware that this consensus of annual earnings estimates for Insmed Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.35 Lowest | Expected EPS | -0.45 Highest |
Insmed Earnings Projection Consensus
Suppose the current estimates of Insmed's value are higher than the current market price of the Insmed stock. In this case, investors may conclude that Insmed is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Insmed's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2026 | Current EPS (TTM) | |
| 20 | 81.49% | 0.0 | -0.8346 | -6.17 |
Insmed Earnings per Share Projection vs Actual
Actual Earning per Share of Insmed refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Insmed Inc predict the company's earnings will be in the future. The higher the earnings per share of Insmed, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Insmed Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Insmed, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Insmed should always be considered in relation to other companies to make a more educated investment decision.Insmed Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Insmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2026-02-19 | 2025-12-31 | -1.17 | -1.54 | -0.37 | 31 | ||
2025-10-29 | 2025-09-30 | -1.32 | -1.75 | -0.43 | 32 | ||
2025-08-07 | 2025-06-30 | -1.3 | -1.7 | -0.4 | 30 | ||
2025-05-07 | 2025-03-31 | -1.2 | -1.42 | -0.22 | 18 | ||
2025-02-20 | 2024-12-31 | -1.23 | -1.32 | -0.09 | 7 | ||
2024-10-31 | 2024-09-30 | -1.22 | -1.27 | -0.05 | 4 | ||
2024-08-08 | 2024-06-30 | -1.27 | -1.94 | -0.67 | 52 | ||
2024-05-09 | 2024-03-31 | -1.23 | -1.06 | 0.17 | 13 | ||
2024-02-22 | 2023-12-31 | -1.15 | -1.28 | -0.13 | 11 | ||
2023-10-26 | 2023-09-30 | -1.13 | -1.11 | 0.02 | 1 | ||
2023-08-03 | 2023-06-30 | -1.13 | -1.78 | -0.65 | 57 | ||
2023-05-04 | 2023-03-31 | -1.11 | -1.17 | -0.06 | 5 | ||
2023-02-23 | 2022-12-31 | -1.04 | -1.21 | -0.17 | 16 | ||
2022-10-27 | 2022-09-30 | -0.89 | -1.09 | -0.2 | 22 | ||
2022-08-04 | 2022-06-30 | -0.89 | -0.8 | 0.09 | 10 | ||
2022-05-05 | 2022-03-31 | -0.88 | -0.8 | 0.08 | 9 | ||
2022-02-17 | 2021-12-31 | -0.9 | -0.95 | -0.05 | 5 | ||
2021-10-28 | 2021-09-30 | -0.86 | -0.89 | -0.03 | 3 | ||
2021-08-05 | 2021-06-30 | -0.85 | -0.91 | -0.06 | 7 | ||
2021-05-06 | 2021-03-31 | -0.89 | -0.89 | 0.0 | 0 | ||
2021-02-25 | 2020-12-31 | -0.7 | -1.0 | -0.3 | 42 | ||
2020-10-29 | 2020-09-30 | -0.61 | -0.63 | -0.02 | 3 | ||
2020-08-06 | 2020-06-30 | -0.63 | -0.64 | -0.01 | 1 | ||
2020-04-30 | 2020-03-31 | -0.71 | -0.74 | -0.03 | 4 | ||
2020-02-25 | 2019-12-31 | -0.58 | -0.59 | -0.01 | 1 | ||
2019-10-30 | 2019-09-30 | -0.67 | -0.68 | -0.01 | 1 | ||
2019-08-01 | 2019-06-30 | -0.86 | -0.81 | 0.05 | 5 | ||
2019-05-07 | 2019-03-31 | -0.95 | -0.96 | -0.01 | 1 | ||
2019-02-22 | 2018-12-31 | -1.05 | -1.19 | -0.14 | 13 | ||
2018-10-30 | 2018-09-30 | -1.06 | -1.14 | -0.08 | 7 | ||
2018-08-02 | 2018-06-30 | -1.08 | -1.0 | 0.08 | 7 | ||
2018-05-02 | 2018-03-31 | -0.98 | -0.89 | 0.09 | 9 | ||
2018-02-23 | 2017-12-31 | -0.64 | -0.85 | -0.21 | 32 | ||
2017-11-02 | 2017-09-30 | -0.69 | -0.69 | 0.0 | 0 | ||
2017-08-03 | 2017-06-30 | -0.63 | -0.72 | -0.09 | 14 | ||
2017-05-03 | 2017-03-31 | -0.6 | -0.6 | 0.0 | 0 | ||
2017-02-23 | 2016-12-31 | -0.89 | -1.1 | -0.21 | 23 | ||
2016-11-03 | 2016-09-30 | -0.59 | -0.61 | -0.02 | 3 | ||
2016-08-04 | 2016-06-30 | -0.56 | -0.59 | -0.03 | 5 | ||
2016-05-05 | 2016-03-31 | -0.56 | -0.54 | 0.02 | 3 | ||
2016-02-25 | 2015-12-31 | -0.49 | -0.51 | -0.02 | 4 | ||
2015-11-06 | 2015-09-30 | -0.47 | -0.5 | -0.03 | 6 | ||
2015-08-06 | 2015-06-30 | -0.48 | -0.47 | 0.01 | 2 | ||
2015-05-07 | 2015-03-31 | -0.5 | -0.55 | -0.05 | 10 | ||
2015-02-27 | 2014-12-31 | -0.56 | -0.36 | 0.2 | 35 | ||
2014-11-06 | 2014-09-30 | -0.46 | -0.54 | -0.08 | 17 | ||
2014-08-06 | 2014-06-30 | -0.46 | -0.59 | -0.13 | 28 | ||
2014-05-08 | 2014-03-31 | -0.41 | -0.36 | 0.05 | 12 | ||
2014-03-06 | 2013-12-31 | -0.45 | -0.41 | 0.04 | 8 | ||
2013-11-05 | 2013-09-30 | -0.41 | -0.46 | -0.05 | 12 | ||
2013-08-06 | 2013-06-30 | -0.32 | -0.28 | 0.04 | 12 | ||
2013-05-07 | 2013-03-31 | -0.46 | -0.43 | 0.03 | 6 | ||
2013-03-18 | 2012-12-31 | -0.32 | -0.49 | -0.17 | 53 | ||
2012-11-07 | 2012-09-30 | -0.42 | -0.38 | 0.04 | 9 | ||
2012-08-07 | 2012-06-30 | -0.33 | -0.39 | -0.06 | 18 | ||
2012-05-08 | 2012-03-31 | -0.38 | -0.28 | 0.1 | 26 | ||
2012-03-13 | 2011-12-31 | -0.38 | -0.3 | 0.08 | 21 | ||
2011-11-08 | 2011-09-30 | -0.28 | -0.34 | -0.06 | 21 | ||
2011-08-08 | 2011-06-30 | -0.33 | -0.4 | -0.07 | 21 | ||
2011-05-11 | 2011-03-31 | -0.32 | -0.85 | -0.53 | 165 | ||
2011-03-10 | 2010-12-31 | -0.1 | -0.42 | -0.32 | 320 | ||
2008-03-04 | 2007-12-31 | -0.3 | -0.3 | 0.0 | 0 | ||
2007-11-08 | 2007-09-30 | -0.4 | -0.3 | 0.1 | 25 | ||
2007-08-02 | 2007-06-30 | -0.5 | -0.2 | 0.3 | 60 | ||
2007-05-10 | 2007-03-31 | -0.75 | -1.0 | -0.25 | 33 | ||
2007-03-15 | 2006-12-31 | -1.25 | -2.1 | -0.85 | 68 | ||
2006-11-03 | 2006-09-30 | -1.05 | -1.2 | -0.15 | 14 | ||
2006-08-08 | 2006-06-30 | -1.6 | -0.9 | 0.7 | 43 | ||
2006-05-08 | 2006-03-31 | -1.3 | -1.7 | -0.4 | 30 | ||
2006-03-02 | 2005-12-31 | -2.1 | -2.7 | -0.6 | 28 | ||
2005-11-03 | 2005-09-30 | -2.1 | -2.9 | -0.8 | 38 | ||
2005-08-08 | 2005-06-30 | -2 | -1.9 | 0.1 | 5 | ||
2005-05-10 | 2005-03-31 | -1.2 | -1.3 | -0.1 | 8 | ||
2004-11-08 | 2004-09-30 | -1.4 | -2.0 | -0.6 | 42 | ||
2004-07-28 | 2004-06-30 | -3.1 | -2.3 | 0.8 | 25 | ||
2004-05-05 | 2004-03-31 | -1 | -1.2 | -0.2 | 20 | ||
2004-02-11 | 2003-12-31 | -0.8 | -0.6 | 0.2 | 25 | ||
2002-01-30 | 2001-12-31 | -3 | -3.0 | 0.0 | 0 | ||
2001-11-01 | 2001-09-30 | -2.93 | -2.5 | 0.43 | 14 | ||
2001-08-02 | 2001-06-30 | -3.25 | -2.7 | 0.55 | 16 | ||
2001-02-01 | 2000-12-31 | -4.45 | -2.6 | 1.85 | 41 |
Use Insmed in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Insmed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insmed will appreciate offsetting losses from the drop in the long position's value.Insmed Pair Trading
Insmed Inc Pair Trading Analysis
The ability to find closely correlated positions to Insmed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Insmed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Insmed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Insmed Inc to buy it.
The correlation of Insmed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Insmed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Insmed Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Insmed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Insmed position
In addition to having Insmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Restaurants Thematic Idea Now
Restaurants
Entities that are involved in restaurant business, as well as coffee shop chains and other eateries. The Restaurants theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaurants Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
To fully project Insmed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Insmed Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Insmed's income statement, its balance sheet, and the statement of cash flows.